Cargando…
A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection
There are two major and alternative pathways to repair DNA double-strand breaks: non-homologous end-joining and homologous recombination. Here we identify and characterize novel factors involved in choosing between these pathways; in this study we took advantage of the SeeSaw Reporter, in which the...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980490/ https://www.ncbi.nlm.nih.gov/pubmed/27503537 http://dx.doi.org/10.1038/ncomms12364 |
_version_ | 1782447463493271552 |
---|---|
author | López-Saavedra, Ana Gómez-Cabello, Daniel Domínguez-Sánchez, María Salud Mejías-Navarro, Fernando Fernández-Ávila, María Jesús Dinant, Christoffel Martínez-Macías, María Isabel Bartek, Jiri Huertas, Pablo |
author_facet | López-Saavedra, Ana Gómez-Cabello, Daniel Domínguez-Sánchez, María Salud Mejías-Navarro, Fernando Fernández-Ávila, María Jesús Dinant, Christoffel Martínez-Macías, María Isabel Bartek, Jiri Huertas, Pablo |
author_sort | López-Saavedra, Ana |
collection | PubMed |
description | There are two major and alternative pathways to repair DNA double-strand breaks: non-homologous end-joining and homologous recombination. Here we identify and characterize novel factors involved in choosing between these pathways; in this study we took advantage of the SeeSaw Reporter, in which the repair of double-strand breaks by homology-independent or -dependent mechanisms is distinguished by the accumulation of green or red fluorescence, respectively. Using a genome-wide human esiRNA (endoribonuclease-prepared siRNA) library, we isolate genes that control the recombination/end-joining ratio. Here we report that two distinct sets of genes are involved in the control of the balance between NHEJ and HR: those that are required to facilitate recombination and those that favour NHEJ. This last category includes CCAR2/DBC1, which we show inhibits recombination by limiting the initiation and the extent of DNA end resection, thereby acting as an antagonist of CtIP. |
format | Online Article Text |
id | pubmed-4980490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-49804902016-08-12 A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection López-Saavedra, Ana Gómez-Cabello, Daniel Domínguez-Sánchez, María Salud Mejías-Navarro, Fernando Fernández-Ávila, María Jesús Dinant, Christoffel Martínez-Macías, María Isabel Bartek, Jiri Huertas, Pablo Nat Commun Article There are two major and alternative pathways to repair DNA double-strand breaks: non-homologous end-joining and homologous recombination. Here we identify and characterize novel factors involved in choosing between these pathways; in this study we took advantage of the SeeSaw Reporter, in which the repair of double-strand breaks by homology-independent or -dependent mechanisms is distinguished by the accumulation of green or red fluorescence, respectively. Using a genome-wide human esiRNA (endoribonuclease-prepared siRNA) library, we isolate genes that control the recombination/end-joining ratio. Here we report that two distinct sets of genes are involved in the control of the balance between NHEJ and HR: those that are required to facilitate recombination and those that favour NHEJ. This last category includes CCAR2/DBC1, which we show inhibits recombination by limiting the initiation and the extent of DNA end resection, thereby acting as an antagonist of CtIP. Nature Publishing Group 2016-08-09 /pmc/articles/PMC4980490/ /pubmed/27503537 http://dx.doi.org/10.1038/ncomms12364 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article López-Saavedra, Ana Gómez-Cabello, Daniel Domínguez-Sánchez, María Salud Mejías-Navarro, Fernando Fernández-Ávila, María Jesús Dinant, Christoffel Martínez-Macías, María Isabel Bartek, Jiri Huertas, Pablo A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection |
title | A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection |
title_full | A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection |
title_fullStr | A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection |
title_full_unstemmed | A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection |
title_short | A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection |
title_sort | genome-wide screening uncovers the role of ccar2 as an antagonist of dna end resection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980490/ https://www.ncbi.nlm.nih.gov/pubmed/27503537 http://dx.doi.org/10.1038/ncomms12364 |
work_keys_str_mv | AT lopezsaavedraana agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT gomezcabellodaniel agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT dominguezsanchezmariasalud agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT mejiasnavarrofernando agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT fernandezavilamariajesus agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT dinantchristoffel agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT martinezmaciasmariaisabel agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT bartekjiri agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT huertaspablo agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT lopezsaavedraana genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT gomezcabellodaniel genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT dominguezsanchezmariasalud genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT mejiasnavarrofernando genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT fernandezavilamariajesus genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT dinantchristoffel genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT martinezmaciasmariaisabel genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT bartekjiri genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection AT huertaspablo genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection |